DGEFX
Price
$14.61
Change
+$0.11 (+0.76%)
Updated
Dec 3 closing price
Net Assets
484.12M
LSVGX
Price
$17.64
Change
+$0.12 (+0.68%)
Updated
Dec 3 closing price
Net Assets
93.23M
Interact to see
Advertisement

DGEFX vs LSVGX

Header iconDGEFX vs LSVGX Comparison
Open Charts DGEFX vs LSVGXBanner chart's image
Destinations Equity Income I
Price$14.61
Change+$0.11 (+0.76%)
VolumeN/A
Net Assets484.12M
LSV Global Value Institutional
Price$17.64
Change+$0.12 (+0.68%)
VolumeN/A
Net Assets93.23M
DGEFX vs LSVGX Comparison Chart in %
View a ticker or compare two or three
VS
DGEFX vs. LSVGX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DGEFX is a Hold and LSVGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
DGEFX has more cash in the bank: 484M vs. LSVGX (93.2M). LSVGX (2.16) and DGEFX (2.13) have matching dividends . DGEFX was incepted earlier than LSVGX: DGEFX (9 years) vs LSVGX (11 years). DGEFX (1.07) and LSVGX (1.05) have similar cost to investors . DGEFX is a more actively managed with annual turnover of: 45.00 vs. LSVGX (12.00). DGEFX has a lower initial minimum investment than LSVGX: DGEFX (0) vs LSVGX (100000). LSVGX annual gain was more profitable for investors over the last year : 15.04 vs. DGEFX (13.03). LSVGX return over 5 years is better than : 74.54 vs. DGEFX (65.77).
DGEFXLSVGXDGEFX / LSVGX
Total Expense Ratio0.940.90104%
Annual Report Gross Expense Ratio1.071.05102%
Fund Existence9 years11 years-
Gain YTD17.79523.42576%
Front LoadN/AN/A-
Min. Initial Investment0100000-
Min. Initial Investment IRAN/AN/A-
Net Assets484M93.2M519%
Annual Yield % from dividends2.132.1699%
Returns for 1 year13.0315.0487%
Returns for 3 years33.7449.3668%
Returns for 5 years65.7774.5488%
Returns for 10 yearsN/A121.65-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CMOPF81.79N/A
N/A
Cosmo Pharmaceuticals NV
GMVHF10.65N/A
N/A
ENTAIN PLC
KBCSF119.42N/A
N/A
KBC Group SA
PRVCF0.02N/A
N/A
PreveCeutical Medical Inc.
IRCDF1.37N/A
N/A
Intercede Group PLC